To check AmotL2 involvement in inflammation and toxicity elicited by OxPt-based chemotherapy in the ENS, AmotL2 and TNF-α co-immunostaining was performed in non-tumor colon sections from non-treated and from OxPt-treated patients, (Figure 5). This evidence concerns the gene TNF and neoplasm.